Illinois Prescription Monitoring Program. Sarah Pointer, Pharm D. Clinical Director of the Illinois Prescription Monitoring Program
|
|
|
- Egbert Rogers
- 5 years ago
- Views:
Transcription
1 Illinois Prescription Monitoring Program Sarah Pointer, Pharm D. Clinical Director of the Illinois Prescription Monitoring Program
2 Agenda Provide an overview of the Illinois Prescription Monitoring Program (IL-PMP) PMP initiatives Project Update Technical Update Legislative Update
3 Illinois Prescription Monitoring Program Overview The ILPMP receives Controlled Substance prescription data from retail pharmacies on an end of next business day basis and allows Prescribers and Dispensers to view the historical data for current and prospective patients.
4 ILPMP.org
5 PMP Initiatives: Prevent drug overdoses/drug misuse Identify High Risk Behaviors Intervention focus Increase accessibility Designee Capabilties PMPnow
6 State of Illinois Opioid Action Plan
7 CDC Guideline for Prescribing Opioids for Chronic Pain Clinicians should review the patient s history of controlled substance prescriptions using state prescription drug monitoring program (PDMP) data to determine whether the patient is receiving opioid dosages or dangerous combinations that put him or her at high risk for overdose. Clinicians should review PDMP data when starting opioid therapy for chronic pain and periodically during opioid therapy for chronic pain, ranging from every prescription to every 3 months
8 PMP Data Identify high risk patients and prescribers High Burdened areas Focus intervention efforts
9
10
11 Unsolicited Prescriber Letters MPE Alerts and thresholds Targeted Prescribers Letters High Risk Prescribers High MME daily dosing BZD / Opioid co-prescribing BZD / Hypnotic co-prescribing High Prescribers Based on average daily MME
12 Upcoming changes to ILPMP website
13 13
14 14
15 PMP Initiative: Increase access by medical providers Designees Capabilities EHR Integration - PMPnow
16 Designee Capabilties The prescriber or dispenser shall only have up to three designees. The prescriber and dispenser shall register the designees and must also agree to the terms and conditions for designees. Each designee shall have an individual account that must be linked to the prescriber or dispenser
17 PMPnow Direct access of the PMP through the EHR Makes PMP more accessible to prescribers Ability to integrate with any EHR system
18 PMP Website Medication Review Flow: User logs in twice to PMP & EHR for a clear picture of medication use Before Integration EHR PMP 18
19 PMPnow EHR-PMP Pathway: User logs into EHR and navigates to a tab to view PMP data After Integration EHR PMP 19
20 20 PMPnow Over 100 hospitals connected! Promotion Initiative IHA collaboration EHR vendor marketing Facility Outreach RxCheck Hub Pilot Interstate data via PMPnow
21 2017 to Current PMPnow Searches 4,349,166 PMPnow Searches in May PMPnow Searches will exceed 2017 total before July 1 st,
22 Project Updates
23 Academic Detailing UIC Project Continuing Education Contract with SIU Community Outreach Newsletter County reports
24 New Pilot Projects
25 Medical Marijuana Naloxone Administration Reporting Coroner / Medical Examiner Access
26 Legislative Update
27 Public Act Effective January 1, 2018, each prescriber possessing an Illinois controlled substances license shall register with the Prescription Monitoring Program.
28 ILPMP Registrations PMPI Role (user selected) IDFPR Licensed (Dec 2017) ILPMP Registrants Physician 39,196 31,348 Nurse Practitioner 9,210 7,219 Dentist 9,734 4,727 Physician Assistant with prescriptive authority 3,160 3,115 Medical Resident with prescriptive authority 5,474 2,572 Other Prescriber, Designee or Indirect Access 2,551 Veterinarian 3,286 2,134 Optometrist with prescriptive authority 1, Pharmacist 17,545 11,241 Totals 89,563 65,806
29 SB772 / Public Act Each Prescriber (or their designee) shall document an attempt to access the PMP to assess the patient on initial prescription of a Schedule II narcotic (opioid) - such documentation shall be in the patient's medical record; Exceptions: Oncology Treatment Palliative Care 7-Day or less supply provided by an Emergency Department (treating an acute, traumatic medical condition)
30 30 PMP Searches by Year Year Searches ,431, ,232, ,713, ,698, ,377, (Jan through May) 20,072,583
31 SB772 / Public Act By 2021, the PMP shall interface with Electronic Health Record systems and shall include integration of pharmacy records with the PMP to enhance transfer of information
32 PMPnow WE WILL CONNECT TO ANY HEALTHCARE ORGANIZATION THAT WOULD LIKE TO RECEIVE PMP DATA!!!
33 Questions?
The Wisconsin Prescription Drug Monitoring Program
The Wisconsin Prescription Drug Monitoring Program DHS 2018 WI Opioid Forum April 12, 2018 Learning Objectives 1. How the WI epdmp supports healthcare professionals in making informed prescribing, dispensing
The Wisconsin Prescription Drug Monitoring Program. WI PDMP Timeline. PDMP Overview. What is a PDMP? PDMPs Across the Nation. Wisconsin.
The Wisconsin Prescription Drug Monitoring Program Wisconsin Nurses Association Jail Health Care Conference May 21, 2018 WI PDMP Timeline PDMP Overview January 2013 WI PDMP operational April 2017 WI epdmp
ANNUAL REPORT
ANNUAL REPORT - 2015 New Hampshire Prescription Drug Monitoring Program Report for July 1, 2014 June 30, 2015 Published October 2015 Table of Contents Executive Summary... 3-4 NH PDMP Background Information
North Dakota Board of Pharmacy
North Dakota Board of Pharmacy Updates on Drug Abuse Trends, the PDMP and Medical Marijuana Mark J. Hardy, Pharm D Executive Director Disclosure Statement I have no conflict of interests to report Objectives
COLORADO PRESCRIPTION DRUG MONITORING PROGRAM
COLORADO PRESCRIPTION DRUG MONITORING PROGRAM Harold Rogers Prescription Drug Monitoring Program West Regional Meeting Salt Lake City, Utah August 12 13, 2014 Tia Stakely, M.S. PDMP Administrator 2005
Presentation Objectives
Oregon s PDMP 101 Lisa Millet, MSH, Section Manager Injury and Violence Prevention Section Center for Prevention and Health Promotion Oregon Health Authority Eugene Oregon PDO Summit April 20, 2016 1 Presentation
Louisiana. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Louisiana Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
Prescription Drug Monitoring Programs and Other State-Level Strategies
Prescription Drug Monitoring Programs and Other State-Level Strategies Interventions to Reduce Opioid-Related Harms: Misuse, Abuse, Addiction, and Overdose Tamara M. Haegerich, PhD Acting Associate Director
Shannon Whitman Program Administrator Advancing Use of the MN PMP
Shannon Whitman Program Administrator Advancing Use of the MN PMP TODAY S OBJECTIVE What is a PMP/PDMP, why do we need one? What is the national status of PMPs? Minnesota s intent of the PMP What does
4/24/15. New Mexico s Prescription Monitoring Program. Carl Flansbaum, RPh. PMP Director New Mexico Board of Pharmacy. New Mexico and the PMP
New Mexico s Carl Flansbaum, RPh. PMP Director New Mexico Board of Pharmacy New Mexico and the PMP In 2012, New Mexico had the 3 nd Highest Overdose Death Rate in Nation.! 492 Deaths or a rate of 23.6
Prescription Monitoring Program (PMP)
06/15/2018 FACT SHEET Implementation of Enacted Prescribing Limits and Requirements and Relevant Opioid Prescribing Laws and Rules Background: The 2016 law (Chapter 488) makes five major changes to opioid
April 26, New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Board of Pharmacy Prescription Monitoring Program (PMP)
New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Nurse Practitioner Council New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) Peter Ryba, PharmD PMP Director
SCRIPTS. South Carolina Reporting & Identification Prescription Tracking System
SCRIPTS South Carolina Reporting & Identification Prescription Tracking System Accidental Deaths 3 Due to Drug Overdose SC Occurrence Data Accidental Drug Overdose Year # of Deaths All deaths Drug not
Arkansas Department of Health
Arkansas Department of Health 4815 West Markham Street Little Rock, Arkansas 72205-3867 Telephone (501) 661-2000 Governor Mike Beebe Nathaniel Smith, MD, MPH, Interim Director and State Health Officer
Wisconsin Statewide Substance Abuse Prevention Training Wisconsin Dells June 12, 2015
Wisconsin Statewide Substance Abuse Prevention Training Wisconsin Dells June 12, 2015 1 Presenter Andrea Magermans Program Analyst of the Wisconsin PDMP Wisconsin Department of Safety and Professional
PDMP Tools to Identify Red Flag Situations
PDMP Tools to Identify Red Flag Situations Prescription Drug Monitoring Programs CBI Baltimore, MD February 7, 2017 Grant Carrow, Ph.D. Project Consultant The Heller School for Social Policy and Management
State, District, or Territory Criteria for Mandatory Query of PDMP
State, District, or Territory Alabama Alaska Arizona Criteria for Mandatory Query of PDMP Requirements for use of the PMP, including the following: 1) when prescribing a patient a controlled substance
Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable
Arizona Amends worker s compensation statute to require physicians to request PMP information within two (2) business days of writing or dispensing prescriptions for at least a 30 day supply of an opioid
Dispensing and administration of emergency opioid antagonist without a
68-7-23. Dispensing and administration of emergency opioid antagonist without a prescription. (a) A pharmacist may dispense an FDA-approved emergency opioid antagonist and the necessary medical supplies
Confronting the Opioid Epidemic
Confronting the Opioid Epidemic Appropriately Treating Pain while Stopping Abuse Scott Kennedy, MD, Chief Medical Officer, Olympic Medical Center Ian Corbridge, RN, Clinical Policy Director, WSHA June
Rhode Island. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Rhode Island Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable
Alaska Requires adoption of regulations that provide that a practitioner query the PDMP prior to dispensing, prescribing, or administering a Sch. II or III controlled substance; query is not required for
Medicare Part D Prescription Opioid Policies for 2019 Information for Pharmacists
CENTERS FOR MEDICARE & MEDICAID SERVICES Medicare Part D Prescription Opioid Policies for 2019 Information for Pharmacists Background Opioid medications are effective at treating certain types of pain,
D. Todd Bess, PharmD 1
s Program as a Tool to Improve Patient Care and Fight the Drug Epidemic D. Todd Bess, Pharm.D. Director April 12, 2018 Disclosure Information I have no financial relationships to disclose. I will not discuss
Prescription Drug Monitoring Program Update. Rebecca R. Poston, BPharm., MHL Program Manager August 26, 2017
Prescription Drug Monitoring Program Update Rebecca R. Poston, BPharm., MHL Program Manager August 26, 2017 Objectives Brief historical overview of opioids Review of PDMP information Discuss ideas from
The Oregon Opioid Initiative. State Pain & Opioid Conference Prescription Drug Monitoring May 2018 Lisa Millet, Public Health Division
The Oregon Opioid Initiative State Pain & Opioid Conference Prescription Drug Monitoring May 2018 Lisa Millet, Public Health Division Disclosure No disclosures 2 Learning Objectives Learner will be able
States with Authority to Require Nonresident Pharmacies to Report to PMP
States with Authority to Require Nonresident Pharmacies to Report to PMP Research current through May 2016. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug
Supplement No. 1 published with Extraordinary Gazette No. 65 dated 19 th August, 2016.
CAYMAN ISLANDS Supplement No. 1 published with Extraordinary Gazette No. 65 dated 19 th August, 2016. A BILL FOR A LAW TO AMEND THE MISUSE OF DRUGS LAW (2014 REVISION) TO INCLUDE CANNABIS EXTRACTS AND
4/26/2018. Bureau of Professional Licensing. MAPS Updates & Opportunities. MAPS Background. Registration. MAPS Update
Bureau of Professional Licensing MAPS Updates & Opportunities April 28, 2018 Presented by Andrew Hudson, Manager Haley Winans, Analyst Drug Monitoring Section Bureau of Professional Licensing BPL-MAPS@Michigan.gov
California. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile California Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
Oregon Prescription Drug Monitoring Program
Oregon Prescription Drug Monitoring Program 2013 Annual Report to the PDMP Advisory Commission PUBLIC HEALTH DIVISION Prescription Drug Monitoring Program Oregon Prescription Drug Monitoring Program 2013
PROJECT DOVE. Improving Maternal and Neonatal Health Through Safer Opioid Prescribing
PROJECT DOVE Improving Maternal and Neonatal Health Through Safer Opioid Prescribing PARTNERS SUPPORT Bureau of Justice Assistance, Department of Justice Rhode Island Opportunity Non-medical prescription
Illinois Heroin Crisis Act and Family Physicians. October 14, 2015 Hinsdale Family Medicine Residency Faculty Development Program
Illinois Heroin Crisis Act and Family Physicians October 14, 2015 Hinsdale Family Medicine Residency Faculty Development Program Your speaker s disclosures Executive vice president, Illinois Academy of
Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable
Arizona Amends worker s compensation statute to require physicians to request PMP information within two (2) business days of writing or dispensing prescriptions for at least a 30 day supply of an opioid
Project Update: Comparing South Dakota Prescription Drug Monitoring Program Law Enforcement Profile Requests to Criminal History Data
Project Update: Comparing South Dakota Prescription Drug Monitoring Program Law Enforcement Profile Requests to Criminal History Data Presented to Bureau of Justice Assistance Harold Rogers Prescription
Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable
Alabama Requirements for use of the PMP, including the following: 1) when prescribing a patient a controlled substance of more than 30 MME per day, physicians shall query the PMP for that patient at least
PRESCRIPTION DRUG MONITORING PROGRAM ST. CHARLES COUNTY Q1 2018
PRESCRIPTION DRUG MONITORING PROGRAM ST. CHARLES COUNTY Q1 2018 Contents Executive Summary... 2 User Registration & System Utilization... 4 Dispensation Rates... 6 Dispensation Rates by Geography... 6
New Mexico. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile New Mexico Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
New Mexico Board of Pharmacy Prescription Monitoring Program (PMP)
New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) PDMP West Regional Meeting PMP Collaboration with the NM Department of Health April 26, 2018 New Mexico Board of Pharmacy Prescription
Opioid Guardianship Project: Combating the Opioid Crisis Sarah Derr, PharmD Meg Nugent, MHA, RN Iowa Healthcare Collaborative
Opioid Guardianship Project: Combating the Opioid Crisis Sarah Derr, PharmD Meg Nugent, MHA, RN Iowa Healthcare Collaborative Objectives Summarize the current crisis at the national and Iowa state level.
Prescription Opioid Overdose in Oregon: A public health perspective
Prescription Opioid Overdose in Oregon: A public health perspective Katrina Hedberg, MD, MPH Health Officer & State Epidemiologist Oregon Public Health Division Oregon Health Authority All-Cause Mortality,
WHAT YOU NEED TO KNOW TO ABOUT AB 474
WHAT YOU NEED TO KNOW TO ABOUT AB 474 PRESENTED BY: NEVADA STATE BOARD OF OSTEOPATHIC MEDICINE 2275 Corporate Circle, Suite 210 Henderson, NV 89074 702-732-2147 Fax 702-732-2079 Web Site: www.bom.nv.gov
CDC s Approach to Addressing the Opioid Overdose Epidemic
CDC s Approach to Addressing the Opioid Overdose Epidemic Sarah Bacon National Center for Injury Prevention and Control Division of Unintentional Injury Prevention June 23, 2016 500,000 drug overdose deaths
BOARD OF PHARMACY- REGULATORY UPDATE. Kimberly Grinston, J.D., Executive Director
BOARD OF PHARMACY- REGULATORY UPDATE Kimberly Grinston, J.D., Executive Director Disclosure and Conflict of Interest I declare no conflicts of interest, real or apparent, and no financial interest in any
Opioid Abuse and Prescribing. Dr. Mitchell Mutter Director of Special Projects
Opioid Abuse and Prescribing Dr. Mitchell Mutter Director of Special Projects Auburn University February 22, 2019 Disclosure Statement of Financial Interest I, Mitchell Mutter, DO NOT have a financial
Tennessee. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Tennessee Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
Nebraska: What s Going On with the PDMP and HIE
Nebraska: What s Going On with the PDMP and HIE Kevin C. Borcher, PharmD PDMP Program Director NeHII, Inc. BJA PDMP North Regional Meeting October 16, 2018 Nebraska PDMP Legislative Summary LB 237 (2011)
PRESCRIPTION DRUG MONITORING PROGRAM
PRESCRIPTION DRUG MONITORING PROGRAM ST. LOUIS COUNTY Q2 2017 Contents Executive Summary... 2 User Registration & System Utilization... 4 Dispensation Rates... 6 Dispensation Rates by Geography... 6 Dispensation
Opioid Safety: Prescribing Guidelines, Quality Measures and Care Coordination Best-Practices
Opioid Safety: Prescribing Guidelines, Quality Measures and Care Coordination Best-Practices August 25, 2017 Presented by Michael Crooks, PharmD. Medication Safety and Care Coordination Task Lead 8/28/2017
Virginia. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Virginia Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
It Takes A Village to Curb the Prescription Opioid Epidemic: Supply healthcare providers with resources to improve patient safety
Session L6 This presenter has nothing to disclose It Takes A Village to Curb the Prescription Opioid Epidemic: CDC Efforts Jan Losby, PhD Team Lead, Overdose Prevention Health Systems Team Division of
Arkansas Prescription Monitoring Program
Arkansas Prescription Monitoring Program FY 2017 Second Quarter Report October December 2016 Arkansas Prescription Monitoring Program Quarterly Report October December, Fiscal year 2017 Act 304 of 2011
Oklahoma. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Oklahoma Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
Reducing Opioid Over- Prescribing in a Large Integrated Health Care System
Session L6 This presenter has nothing to disclose It Takes a Village to Curb the Prescription Opioid Epidemic: Reducing Opioid Over- Prescribing in a Large Integrated Health Care System Joel D. Hyatt,
Harold Rogers Prescription Drug Monitoring Program Regional Meeting-Charleston, SC April 29, 2014 Andrew Holt, PharmD
Harold Rogers Prescription Drug Monitoring Program Regional Meeting-Charleston, SC April 29, 2014 Andrew Holt, PharmD National Epidemic Highlighted numerous studies/media reports State Epidemic Highlighted
Safe States Alliance 2018 Innovative Initiatives Finalist Summaries for Review
Safe States Alliance 2018 Innovative Initiatives Finalist Summaries for Review 1 Initiative #1: Aiming for Equity in Sexual Violence Prevention - Mapping Risks, Policies, Outcomes and Resources Statement
The Role of the PDMP: Foundational Knowledge and Best Practices
The Role of the PDMP: Foundational Knowledge and Best Practices Brent I. Fox, PharmD, PhD Health Outcomes Research and Policy Harrison School of Pharmacy Auburn University DISCLOSURE I, Brent Fox, have
Report to the Legislature: Unsolicited Reporting Criteria Established and Process Review MN Prescription Monitoring Program
This document is made available electronically by the Minnesota Legislative Reference Library as part of an ongoing digital archiving project. http://www.leg.state.mn.us/lrl/lrl.asp Minnesota Board of
Opioid Prescribing Improvement Program
Opioid Prescribing Improvement Program Jeff Schiff, MD, MBA, Medical Director of Minnesota Health Care Programs Sarah Rinn, MPH, Opioid Prescribing Improvement Program Coordinator Agenda Opioid Prescribing
Minnesota. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Minnesota Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
Oregon Opioid Overdose Prevention Initiative
Oregon Opioid Overdose Prevention Initiative Katrina Hedberg, MD, MPH Health Officer & State Epidemiologist Oregon Public Health Division Oregon Association of Hospitals & Health Systems February 2017
Tri-County Region Opioid Trends Clackamas, Multnomah, and Washington, Oregon. Executive Summary
Tri-County Region Opioid Trends Clackamas, Multnomah, and Washington, Oregon 2016 Executive Summary 20.8 million people in the United States have a substance use disorder (not limited to opioids), equivalent
Our Journey to Addressing the PA PDMP Program. Dean Parry, RPh AVP Clinical Informatics, Care Support Services Geisinger Health System
Our Journey to Addressing the PA PDMP Program Dean Parry, RPh AVP Clinical Informatics, Care Support Services Geisinger Health System 1 Geisinger Health System Geisinger Health System is an integrated
New Medicare Part D Prescription Opioid Policies for 2019 Information for Prescribers
CENTERS FOR MEDICARE & MEDICAID SERVICES New Medicare Part D Prescription Opioid Policies for 2019 Information for Prescribers Background CMS understands the magnitude of the nation s opioid epidemic and
Why pay for Continuing Education when you can get it for FREE!?
Why pay for Continuing Education when you can get it for FREE!? Special Projects Coordinator Arizona Center for Rural Health 9/15/17 This publication was supported by the Grant Number 1U17CE002717-01,
TN Opioid Program. Erica Schlesinger, Pharm.D
TN Opioid Program Erica Schlesinger, Pharm.D Nothing to disclose Disclosures TN Together Governor Haslam s Plan Prevention Establishes limits, decreases supply and dosage of prescription opioids Limits
Utah. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Utah Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points of view
Arkansas Prescription Monitoring Program
Arkansas Prescription Monitoring Program FY 2016 Third Quarter Report January-March 2016 Arkansas Prescription Monitoring Program Quarterly Report January March, Fiscal year 2016 Act 304 of 2011 authorized
FHA CONNECT and Prescription Drug Monitoring
OS/ASA/OCIO/IO FHA CONNECT and Prescription Drug Monitoring Accessing patient prescription data by connecting to the Appriss PMP Gateway Jason Smith, Development Manager FHA CONNECT Robert Tagalicod, HHS
Sub. S.B. 119 As Passed by the Senate
AM3404 Sub. S.B. 119 As Passed by the Senate Topic: Opioid Data and Communication Expansion Act moved to amend as follows: In line 1 of the title, after "4723.52," insert "4729.01, 4729.44, 4729.75, 4729.79,
State, District, or Territory Criteria for Mandatory Enrol ment or Query of PDMP
State, District, or Territory Alabama Arizona Arkansas Criteria for Mandatory Enrollment or Query of PDMP Before renewing an Alabama Controlled Substances Certificate, the applicant shall have a current
Using Prescription Drug Monitoring Program Data to Advance Prevention Planning
September 13, 2016 Using Prescription Drug Monitoring Program Data to Advance Prevention Planning Emerging Drug Issues and Trends Chelsey Goddard, Director, SAMHSA s Center for the Application of Prevention
Rule Governing the Prescribing of Opioids for Pain
Rule Governing the Prescribing of Opioids for Pain 1.0 Authority This rule is adopted pursuant to Sections 14(e) and 11(e) of Act 75 (2013) and Sections 2(e) and 2a of Act 173 (2016). 2.0 Purpose This
Addressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention
The Accountable Community for Health of King County Addressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention May 7, 2018 1 Opiate Treatment & Overdose Prevention Project Goal Immediate:
9/17/2018. Capstone Committee Chair Dr. Brenda Cassidy, DNP, RN, PCNP-PC Assistant Professor Health Promotion and Development
Evaluating Emergency Department Opioid Prescribing Behaviors after Education about Mandated Use of the Pennsylvania Prescription Drug Monitoring Program Jennifer Martello, DNP, RN, FNP-BC University of
Managing Risks Associated with Doctor Shopping and Other Drug-Seeking Behaviors
Managing Risks Associated with Doctor Shopping and Other Drug-Seeking Behaviors This educational call is sponsored by the Enterprise Risk Management Task Force. Thursday, April 11, 2013 11:00 am 12:00
Provider Education & Utilization Initiatives Alliance of States with PMPs East Regional Meeting
Provider Education & Utilization Initiatives Alliance of States with PMPs East Regional Meeting Baltimore, MD April 5, 2011 Massachusetts Department of Public Health MA Prescription Monitoring Program
Report to the Legislature: Impact of the Minnesota Prescription Monitoring Program on Doctor Shopping
Minnesota Board of Pharmacy Report to the Legislature: Impact of the Minnesota Prescription Monitoring Program on Doctor Shopping Prepared By: Dr. Katrina Howard, PMP Pharmacist Consultant October 31,
Prescription Drug Monitoring Program (PDMP)
Prescription Drug Monitoring Program (PDMP) District of Columbia Information contained in this presentation is accurate as of September 2017 Meet the Speaker Tadessa Harper-Nichols Program Specialist Pharmaceutical
Performance of North Carolina's System for Monitoring Prescription Drug Abuse. Session Law , Section 12F.16.(q)
Performance of North Carolina's System for Monitoring Prescription Drug Abuse Session Law 2015-241, Section 12F.16.(q) Report to the Joint Legislative Oversight Committee on Health and Human Services and
ScO.S. Academic Detailing for Safer Prescribing
ScO.S. Academic Detailing for Safer Prescribing Sarah Ball, PharmD Research Assistant Professor MUSC College of Medicine September 6, 2017 Megan Pruitt, PharmD SCORxE Clinical Pharmacy Consultant MUSC
Prescription Monitoring Program Center for Excellence, Brandeis University. April 10-12, 2012 Walt Disney World Swan Resort
Prescription Monitoring Program Center for Excellence, Brandeis University April 10-12, 2012 Walt Disney World Swan Resort Accepted Learning Objectives: 1. Explain the current capabilities and contributions
PMP Advisory Committee. Chair: Sarah Pointer, Pharm D. PMP Admin: Craig Berberet September 20, 2017
PMP Advisory Committee Chair: Sarah Pointer, Pharm D. PMP Admin: Craig Berberet September 20, 2017 PMP Advisory Committee September 20th, 2017 12:00 to 1:30 PM I. Roll Call of Voting Members II. Meeting
STATE PRESCRIPTION DRUG MONITORING PROGRAMS (PMPS): A NATIONAL PERSPECTIVE
STATE PRESCRIPTION DRUG MONITORING PROGRAMS (PMPS): A NATIONAL PERSPECTIVE PRESENTATION ON BEHALF OF THE NATIONAL ASSOCIATION OF STATE CONTROLLED SUBSTANCES AUTHORITIES (NASCSA) BY SHERRY L. GREEN OVERVIEW
Meth and Opioid Abuse Prevention Efforts
Meth and Opioid Abuse Prevention Efforts Prescription Drugs/Opioids in South Dakota Departments of Health and Social Services Drug Abuse in South Dakota South Dakota ranked 2 nd lowest in the nation for
Barbour County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report Barbour County
County West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report County The West Virginia Violence and Injury Prevention Program ( VIPP), in collaboration with
West Virginia. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile West Virginia Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
Controlled Substances Board
Controlled Substances Board Report 1 July 1 September 30, 2016 Contact Information Wisconsin Controlled Substances Board Chairperson: Doug Englebert Members: Englebert, Doug, Chairperson Bloom, Alan, Vice
Oregon s PDMP: An epidemiological assist tool
Oregon s PDMP: An epidemiological assist tool Todd Beran Center for Prevention and Health Promotion Oregon Health Authority PDMP TTAC Webinar February 13, 2013 1 Acknowledgements Lisa Millet, MSH, Section
CDC Guideline for Prescribing Opioids for Chronic Pain
National Center for Injury Prevention and Control CDC Guideline for Prescribing Opioids for Chronic Pain John Halpin, MD, MPH Medical Officer Division of Unintentional Injury Prevention Prescription Drug
Medicare Advantage Outreach and Education Bulletin
Medicare Advantage Outreach and Education Bulletin Blue Cross and Blue Shield of Georgia Prescription Drug Monitoring Programs Prescription drug abuse and diversion are acute problems in the area of pain
What Do IACP Members Think?
What Do IACP Members Think? Results of a National Survey of Compounding Practitioners February 27, 2013 Final Summary Results What Do Compounders Think? National Survey of 2,857 pharmacists and technicians
Addressing Challenges Together, One Rock at a Time
Addressing Challenges Together, One Rock at a Time PAMELA SCHWEITZER, PHARM.D., BCACP ASSISTANT SURGEON GENERAL REAR ADMIRAL (RADM), U.S. PUBLIC HEALTH SERVICE E-MAIL: PAMELA.SCHWEITZER@CMS.HHS.GOV @USPHSPHARMACY
Prescription Drugs: Issues in Treatment, Supervision and Case Management
Prescription Drugs: Issues in Treatment, Supervision and Case Management National Association of Drug Court Professionals Washington, DC July 16, 2013 Agenda Overview of prescription drug diversion and
PDMP Track: Linking and Mapping PDMP Data. Gillian Leichtling Acumentra Health Chris Baumgartner, WA State Dept. of Health
PDMP Track: Linking and Mapping PDMP Data Gillian Leichtling Acumentra Health Chris Baumgartner, WA State Dept. of Health Disclosure Statement Gillian Leichtling and Chris Baumgartner have disclosed no
E-Prescribing, EPCS & PDMP: An Update
E-Prescribing, EPCS & PDMP: An Update Melissa A. Kotrys, MPH Chief Executive Officer July 27, 2018 Arizona Health-e Connection is now Health Current Arizona s primary resource for health information technology
Ministry of Health and Long-Term Care. Presentation to the CPSO Methadone Prescribers Conference
Ministry of Health and Long-Term Care Presentation to the CPSO Methadone Prescribers Conference November 9, 2012 Overview Minister s Expert Working Group on Narcotic Addiction OxyNEO and OxyContin: Changes
BJA COAP Category 6 Quarterly Webinar November 29, 2018
BJA COAP Category 6 Quarterly Webinar November 29, 2018 1 Tara Kunkel Senior Drug Policy Advisor Bureau of Justice Assistance 2 1 Select BJA Grant Project Updates Arkansas: Tafarra Haney Illinois: Sarah
Mingo County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report
West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators Report The West Virginia Violence and Injury Prevention Program ( VIPP), in collaboration with the West Virginia Board